Anti-trypanosome therapeutic and diagnostic applications

Details for Australian Patent Application No. 2010317967 (hide)

Owner Universite Bordeaux Segalen Centre National De La Recherche Scientifique

Inventors Coustou Linares, Virginie; Baltz, Theo; Thonnus, Magali

Agent Davies Collison Cave

Pub. Number AU-A-2010317967

PCT Pub. Number WO2011/058055

Priority 0958035 13.11.09 FR

Filing date 10 November 2010

Wipo publication date 19 May 2011

International Classifications

C07K 14/44 Peptides having more than 20 amino acids

A61K 39/005 Medicinal preparations containing antigens or antibodies - Trypanosoma antigens

C07K 16/20 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/30 Mutation or genetic engineering - Genes encoding protozoal proteins, e.g. from Plasmodium, Trypanosoma, Eimeria

G01N 33/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/058055 Priority application(s): WO2011/058055

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010317992-Anti-trypanosomiasis vaccines and diagnostics

2010317963-A panel for a container, a container provided with such container and a method for making same